Search

Regulation of non-surgical cosmetic interventions

As Paul Harris and Mark Henley discussed in a previous article (see here), certification of cosmetic surgery is being encouraged. Sally Taber, from the JCCP, outlines why non-surgical cosmetic interventions are arguably more urgently in need of effective regulation. Regulation...

The mission to provide equal access for the treatment of port wine stain birthmarks

The Vascular Birthmarks Foundation (VBF) is the leading charity in the world for networking individuals with vascular birthmarks, anomalies, and related syndromes (VBARS) into proper medical treatment. The VBF currently monitors over 80,000 individuals / families, worldwide, who are affected...

In conversation with Afshin Mosahebi

We were delighted to catch up with Professor Afshin Mosahebi, renowned Plastic Surgeon at UCL, about his career and the new Masters of Surgery (MS) in Aesthetics and Minimally-Invasive Aesthetics. Can you tell us a little bit about what led...

Duration of botulinum toxin effects: Determining factors and practical recommendations

Botulinum toxin has become a popular drug in aesthetic dermatology and plastic surgery and is used to diminish wrinkles as well as for a number of medical indications. However, current reports suggest the loss of a therapeutic effect over a...

Follow-up interview with Mr Miles Berry Consultant Plastic and Aesthetic Surgeon

The editor’s clarification Andrew Burd: Miles, many thanks indeed for giving the interview that appeared in the first issue of PMFA News (see PMFA News 1(1):24). I read this with great interest as some very topical and sensitive issues were...

Plastic surgery and aesthetic medicine: specialties and specialists

Dr Nikolaos Metatoxos has written an excellent article ‘How to establish a successful practice in aesthetic medicine’, which looks at the business of aesthetic medicine and underlines some very important ethical issues. When comparing hospital doctors and aesthetic medicine practitioners...

Cellulite therapy in 2022 – new treatment options making grades for the new year

World-renowned dermatologist Michael H Gold introduces two of the newest FDA-approved modalities for the treatment of the common skin condition cellulite. Cellulite is one of the most common skin concerns for women. It is estimated that between 80-98% of women...

A short overview of the evolution of botulinum toxin type A formulations

Botulinum toxin type A (BoNT-A) is a potent neurotoxin produced by the bacterium Clostridium botulinum [1]. BoNT-A has been used for various therapeutic and aesthetic purposes, including the treatment of muscle disorders, chronic pain and facial wrinkles [2-4]. Over the...

Recent developments in facelift surgery

Early facelifting procedures were documented in the 1900s, where skin undermining with excess skin excision along the hairline was performed. The 1970s witnessed a major change with an upsurge in public interest in facelift surgery, which led to innovative changes...